Armstrong, A. J., Howard, L., Harrison, M. R., Ramalingam, S., Hoimes, C. J., Shevach, J., Brown, L. C., Kephart, J., Anand, M., Shobe, K., Sant, C. V., Dale, T. J., Hurrelbrink, J., Rasmussen, J., Nanus, D. M., Siddiqui, B. A., Sternberg, C. N., Aparicio, A., Halabi, S., George, D. J. (2026). Phase 2 multicenter trial of chemoimmunotherapy for patients with neuroendocrine or aggressive variant metastatic prostate cancer (CHAMP).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5016